跳至主要内容
临床试验/CTRI/2016/02/006609
CTRI/2016/02/006609进行中(未招募)未知

An observational study evaluating patterns of tumor response and impact on surgical margins following neoadjuvant chemotherapy (NACT) in locally advanced oral cavity tumors.

A0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方
A
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Previously untreated borderline resectable oral cavity SCC i.e T4a lesions with skin induration.
  • 2.Histological proven diagnosis of squamous cell cancer
  • 3.Signed informed consent
  • 4.Adequate organ function
  • Hematological- Hb > 9 g/dL, ANC >= 1.5 x 109/L, platelets >= 100 x 109/L.
  • Liver functions- bilirubin <= 2 x upper limit normal (ULN), S. albumin >= 30 g/L.
  • Renal function- Creatinine <= 2 ULN, Creatinine clearance > 30 mL/min.
  • Performance score (KPS) > 80 or ECOG <= 2

排除标准

  • 1. Distant metastasis present
  • 2.Serious co-morbidities such as severe cardiac failure or severe pulmonary compromise or severe and active infections.
  • 3.Locally advanced unresectable disease (T4b) or inoperable nodal disease
  • 4.Patients not suitable for any chemotherapy.
  • 5.Patient is currently enrolled in a clinical trial for another investigational therapy.
  • 6.Pregnancy

研究者

发起方
A

相似试验